MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1183/13993003.00337-2020

Медицинская библиотека · The European respiratory journal · 2021

Methotrexate and rheumatoid arthritis associated interstitial lung disease.

Juge Pierre-Antoine, Lee Joyce S, Lau Jessica, Kawano-Dourado Leticia, Rojas Serrano Jorge, Sebastiani Marco, Koduri Gouri, Matteson Eric, Bonfiglioli Karina, Sawamura Marcio, Kairalla Ronaldo, Cavagna Lorenzo, Bozzalla Cassione Emanuele, Manfredi Andreina, Mejia Mayra, Rodríguez-Henriquez Pedro, González-Pérez Montserrat I, Falfán-Valencia Ramcés, Buendia-Roldán Ivette, Pérez-Rubio Gloria, Ebstein Esther, Gazal Steven, Borie Raphaël, Ottaviani Sébastien, Kannengiesser Caroline, Wallaert Benoît, Uzunhan Yurdagul, Nunes Hilario, Valeyre Dominique, Saidenberg-Kermanac'h Nathalie, Boissier Marie-Christophe, Wemeau-Stervinou Lidwine, Flipo René-Marc, Marchand-Adam Sylvain, Richette Pascal, Allanore Yannick, Dromer Claire, Truchetet Marie-Elise, Richez Christophe, Schaeverbeke Thierry, Lioté Huguette, Thabut Gabriel, Deane Kevin D, Solomon Joshua J, Doyle Tracy, Ryu Jay H, Rosas Ivan, Holers V Michael, Boileau Catherine, Debray Marie-Pierre, Porcher Raphaël, Schwartz David A, Vassallo Robert, Crestani Bruno, Dieudé Philippe

СтатьяМетаанализПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

QUESTION ADDRESSED BY THE STUDY: Methotrexate (MTX) is a key anchor drug for rheumatoid arthritis (RA) management. Fibrotic interstitial lung disease (ILD) is a common complication of RA. Whether MTX exposure increases the risk of ILD in patients with RA is disputed. We aimed to evaluate the association of prior MTX use with development of RA-ILD.

METHODS

Through a case-control study design with discovery and international replication samples, we examined the association of MTX exposure with ILD in 410 patients with chronic fibrotic ILD associated with RA (RA-ILD) and 673 patients with RA without ILD. Estimates were pooled over the different samples using meta-analysis techniques.

RESULTS

Analysis of the discovery sample revealed an inverse relationship between MTX exposure and RA-ILD (adjusted OR 0.46, 95% CI 0.24-0.90; p=0.022), which was confirmed in the replication samples (pooled adjusted OR 0.39, 95% CI 0.19-0.79; p=0.009). The combined estimate using both the derivation and validation samples revealed an adjusted OR of 0.43 (95% CI 0.26-0.69; p=0.0006). MTX ever-users were less frequent among patients with RA-ILD compared to those without ILD, irrespective of chest high-resolution computed tomography pattern. In patients with RA-ILD, ILD detection was significantly delayed in MTX ever-users compared to never-users (11.4±10.4 years and 4.0±7.4 years, respectively; p<0.001).

ANSWER TO THE QUESTION: Our results suggest that MTX use is not associated with an increased risk of RA-ILD in patients with RA, and that ILD was detected later in MTX-treated patients.

Для цитирования: Juge Pierre-Antoine, Lee Joyce S, Lau Jessica, Kawano-Dourado Leticia, Rojas Serrano Jorge, Sebastiani Marco, Koduri Gouri, Matteson Eric, Bonfiglioli Karina, Sawamura Marcio, Kairalla Ronaldo, Cavagna Lorenzo, Bozzalla Cassione Emanuele, Manfredi Andreina, Mejia Mayra, Rodríguez-Henriquez Pedro, González-Pérez Montserrat I, Falfán-Valencia Ramcés, Buendia-Roldán Ivette, Pérez-Rubio Gloria, Ebstein Esther, Gazal Steven, Borie Raphaël, Ottaviani Sébastien, Kannengiesser Caroline, Wallaert Benoît, Uzunhan Yurdagul, Nunes Hilario, Valeyre Dominique, Saidenberg-Kermanac'h Nathalie, Boissier Marie-Christophe, Wemeau-Stervinou Lidwine, Flipo René-Marc, Marchand-Adam Sylvain, Richette Pascal, Allanore Yannick, Dromer Claire, Truchetet Marie-Elise, Richez Christophe, Schaeverbeke Thierry, Lioté Huguette, Thabut Gabriel, Deane Kevin D, Solomon Joshua J, Doyle Tracy, Ryu Jay H, Rosas Ivan, Holers V Michael, Boileau Catherine, Debray Marie-Pierre, Porcher Raphaël, Schwartz David A, Vassallo Robert, Crestani Bruno, Dieudé Philippe. Methotrexate and rheumatoid arthritis associated interstitial lung disease.. The European respiratory journal. 2021. DOI: 10.1183/13993003.00337-2020.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.